APA (7th ed.) Citation

Aguilar-Cartes, M., Opazo-Ríos, L., Droguett, A., Mas-Fontao, S., Moreno, J. A., Gómez-Guerrero, C., . . . Mezzano, S. (2026). SOCS1 Mimetic Peptide Enhances Empagliflozin Improvement on Kidney Damage in the Type 2 Diabetes Mouse Model BTBR ob/ob. International Journal of Molecular Sciences, 27(5), 2466. https://doi.org/10.3390/ijms27052466

Chicago Style (17th ed.) Citation

Aguilar-Cartes, Marcelo, Lucas Opazo-Ríos, Alejandra Droguett, Sebastian Mas-Fontao, Juan Antonio Moreno, Carmen Gómez-Guerrero, Jesús Egido, and Sergio Mezzano. "SOCS1 Mimetic Peptide Enhances Empagliflozin Improvement on Kidney Damage in the Type 2 Diabetes Mouse Model BTBR Ob/ob." International Journal of Molecular Sciences 27, no. 5 (2026): 2466. https://doi.org/10.3390/ijms27052466.

MLA (9th ed.) Citation

Aguilar-Cartes, Marcelo, et al. "SOCS1 Mimetic Peptide Enhances Empagliflozin Improvement on Kidney Damage in the Type 2 Diabetes Mouse Model BTBR Ob/ob." International Journal of Molecular Sciences, vol. 27, no. 5, 2026, p. 2466, https://doi.org/10.3390/ijms27052466.